24-hour normothermic machine perfusion of discarded human liver grafts: Case series single-center study - 22/08/23
Abstract |
Background |
The persistent shortage of liver allografts contributes to significant waitlist mortality. Normothermic machine perfusion (NMP) has the potential to extend viability and allow liver function evaluation in discarded organs. The main aim of the study was to evaluate the possibility for extended preservation and the potential recovery of non-usable human livers utilizing NMP.
Methods |
6 high-risk human liver grafts that were discarded after national allocation underwent normothermic liver preservation for an extended period of 24 h. Transmedics Organ Care System™ liver perfusion device was used to preserve a donor liver in a functioning, near physiologic state. Parameters of biochemical and synthetic liver function were collected periodically and subsequently analyzed. Liver parenchyma and bile duct biopsies were obtained pre- and 24 h post-NMP.
Results |
4/6 (67%) grafts were DCDs with a median age of 54 (IQR: 42–61) years and median CIT of 262 (IQR: 209–1024) minutes. 5/6 (83%) livers produced a median of 75 ml of bile (Range 55–100) after 24 h of NMP. Lactate dropped to normal levels (<2 mmol/L) for all livers after around 4 h on NMP. The overall cellular architecture, lobular steatosis and necrosis grades were preserved after extended NMP. Biopsies showed improvement of liver parenchyma architecture with reduced inflammation for 2/6 (33%) at the end of the perfusion.
Conclusion |
Prolonged NMP for discarded liver grafts can be safely maintained on NMP and may identify certain grafts that are suitable for transplantation. Further studies utilizing NMP with subsequent transplantation would validate this strategy, as well as existing viability markers.
Le texte complet de cet article est disponible en PDF.Keywords : Normothermic machine perfusion, Discard liver grafts, Organ shortage, Viability markers, DCD, Marginal Graft
Abbreviations : NMP, BOV, WTP, WIT, CIT, LT, DCD, OCS, EBV, NAT, ALT, AST, IBC
Plan
Vol 12
Article 100177- novembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.